IRCT2013062213737N1已完成未知
The effect of chamomile capsule on obstetrical outcomes in post term pregnancy
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 35 years（—）
- 性别
- Female
入选标准
- •Inclusion criterias: pregnant women 18-35 years old; Iranian nationality; have a body mass index less than 30 before pregnancy; low risk pregnancy; with getational age 41 weeks (40 weeks completely) based on LMP or ultrasound in first trimester; no history of recurrent abortion; infertility and undesirable outcomes of pregnancy; single pregnancy; cephalic presentation; alive fetus; weight of fetus between 2500-4000 gram based on physical examination or ultrasonography; cervical bishop score less than 4; intact membranous; normal pelvic according to researcher's exam; normall fetal heart rate and BPP and NST; no sensivity to herbal drugs and non-addicted persons.
- •Exclusion criterias: those who consume them is less than one capsule per day, more than one care session is absent, and appears allergic symptoms.
排除标准
- 未提供
研究者
相似试验
招募中
2 期
Investigation of the effect of chamomile on ovulation induction in patients with polycystic ovary syndromePolycystic ovarian syndrome.Polycystic ovarian syndromeIRCT20170315033085N3Mashhad University of Medical Sciences70
已完成
不适用
Effect of chamomile infusion on blood glucose, lipid profile and serum kidney functionstype 2 diabetes.Non-insulin-dependent diabetes mellitusIRCT2014120918329N2Vice chancellor for research of Shahid Sadoughi University of medical sciences, Yazd, Iran40
已完成
不适用
Evaluation of the effect of chamomile(matricaria chamomilla) extract on severity of anxiety before root canal therapyIRCT20210516051320N1Esfahan University of Medical Sciences64
招募中
早期 1 期
Evaluation of the efficacy of vaginal product based on chamomile for the treatment of dyspareuniaDyspareunia.DyspareuniaIRCT201702197511N3Tehran University of Medical Sciences92
尚未招募
3 期
Investigating the effect of chamomile oral solution on neurological complications caused by chemotherapy regimens containing paclitaxel in cancer patients.Various cancers treated by paclitaxel.malignant neoplasmsC00-C97IRCT20200408046990N14Mashhad University of Medical Sciences40